More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

Island boosts Galidesivir supply as Ebola surges

Aug 20, 2026 at 7:17 PM EDT · Issued by Island Pharmaceuticals Ltd

Filed with ASX · Aug 20, 2026 at 7:17 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/island-boosts-galidesivir-supply-as-ebola-surges

Island Pharmaceuticals Ltd on 6ix

Story so far

  • Investor Presentation - Ebola Clinical ProgramJul 8, 2026
  • Galidesivir approved for treatment use in in Ebola epidemicJul 6, 2026
  • FDA Grants Orphan Designation for Galidesivir in MarburgJun 16, 2026

Earlier from Island Pharmaceuticals

  • Date of AGM & Closing Date for Director NominationsAug 12
  • Cleansing NoticeAug 11
  • Application for quotation of securities - ILAAug 11
  • Investor presentationAug 6
  • Quarterly Appendix 4C and Activities ReportJul 29

Later from Island Pharmaceuticals

  • Preliminary Final ReportAug 26
  • Annual Report to shareholdersAug 26
  • Appendix 4G and Corporate Governance StatementAug 26
  • Pivotal Marburg data secured for Galidesivir FDA pathwayAug 30
  • Annual General Meeting - Rescheduled DateSep 29
All Island Pharmaceuticals news releases↗

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer